Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:technique
|
| gptkbp:aims_to |
identify active compounds
|
| gptkbp:allows |
false positives
|
| gptkbp:applies_to |
cell-based assays
enzyme assays biological assays |
| gptkbp:can_be_used_with |
high-content screening
|
| gptkbp:can_lead_to |
lead compounds
|
| gptkbp:facilitates |
gptkb:Database_Management_System
gptkb:Cloud_Computing_Service gptkb:robot data visualization tools workflow management systems robotic arms high-throughput sequencers imaging systems bioassays cell culture systems screening platforms microplate readers liquid handling systems automated liquid handlers compound libraries sample management systems |
| https://www.w3.org/2000/01/rdf-schema#label |
High-Throughput Screening
|
| gptkbp:involves |
data analysis
automation |
| gptkbp:is_adopted_by |
biotech companies
|
| gptkbp:is_associated_with |
high data throughput
|
| gptkbp:is_challenged_by |
data management issues
|
| gptkbp:is_characterized_by |
large sample sizes
|
| gptkbp:is_critical_for |
personalized medicine
|
| gptkbp:is_enhanced_by |
gptkb:software_framework
computational methods |
| gptkbp:is_evaluated_by |
efficacy
potency hit rate selectivity |
| gptkbp:is_fundamental_to |
systems biology
|
| gptkbp:is_implemented_in |
gptkb:academic_research
|
| gptkbp:is_influenced_by |
assay design
|
| gptkbp:is_part_of |
pharmaceutical research
preclinical development |
| gptkbp:is_recognized_by |
biomarkers
|
| gptkbp:is_related_to |
screening libraries
|
| gptkbp:is_supported_by |
bioinformatics tools
|
| gptkbp:is_used_for |
genetic studies
target identification chemical screening |
| gptkbp:is_used_in |
toxicology studies
|
| gptkbp:is_utilized_in |
clinical trials
|
| gptkbp:performed_by |
research laboratories
|
| gptkbp:requires |
specialized equipment
|
| gptkbp:used_in |
drug discovery
|
| gptkbp:bfsParent |
gptkb:AI_for_Drug_Discovery
|
| gptkbp:bfsLayer |
4
|